PT-2023-20987 · Xpand It · Xpand It Write-Back Manager

Published 2023-10-26 · Updated 2023-11-07 · CVE-2023-27170

Positive Technologies (AI Summary)

CVSS v3.1

7.5

High

Base vector

AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H

Name of the Vulnerable Software and Affected Versions Xpand IT Write-back manager version 2.3.1

Description The issue allows attackers to perform a directory traversal via modification of the siteName parameter. This enables unauthorized access to sensitive files and directories.

Recommendations For Xpand IT Write-back manager version 2.3.1, avoid using the siteName parameter in affected API endpoints until the issue is resolved. As a temporary workaround, consider restricting access to sensitive files and directories to minimize the risk of exploitation. At the moment, there is no information about a newer version that contains a fix for this vulnerability.

Exploit

Path traversal

Weakness Enumeration

CWE-22

Related Identifiers

CVE-2023-27170

Affected Products

Xpand It Write-Back Manager

References · 5

• 🔥 https://balwurk.com/cve-2023-27170-improper-limitation-of-a-pathname-to-a-restricted-directory · Exploit
• https://osv.dev/vulnerability/CVE-2023-27170 · Vendor Advisory
• https://nvd.nist.gov/vuln/detail/CVE-2023-27170 · Security Note
• https://t.me/cibsecurity/73026 · Telegram Post
• https://twitter.com/CVEnew/status/1717669768734331370 · Twitter Post